If I had an acute coronary syndrome, which antiplatelet agent would I prefer?
description
Transcript of If I had an acute coronary syndrome, which antiplatelet agent would I prefer?
![Page 1: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/1.jpg)
www.metcardio.org
If I had an acute coronary syndrome, which antiplatelet agent would I
prefer?
Giuseppe Biondi Zoccai, MD, FSICI-GISEDivision of Cardiology
University of Modena and Reggio [email protected]
![Page 2: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/2.jpg)
www.metcardio.org
LEARNING GOALS
• SCOPE OF THE PROBLEM
• MENU A LA CARTE OR TABLE D’HOTE?
• MY OWN RECIPE
![Page 3: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/3.jpg)
www.metcardio.org
LEARNING GOALS
• SCOPE OF THE PROBLEM
• MENU A LA CARTE OR TABLE D’HOTE?
• MY OWN RECIPE
![Page 4: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/4.jpg)
www.metcardio.org
ACUTE CORONARY SYNDROMES
Antithrombotictherapy &
(selectively)invasive
management
Stable angina
Unstableangina
Reperfusion(thrombolysis and/or PTCA)
Minutes Hours
DaysWeeks
STEMIUA/NSTEMIAtherothrombosisNew terms
Old terms
Plaque rupture
Non-Q MI Q-MI
![Page 5: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/5.jpg)
www.metcardio.org
SCOPE OF THE PROBLEMThrombotic eventsThrombotic events
Myocardial Myocardial ischemiaischemia
BleedingBleeding
Peri-procedural Peri-procedural complicationscomplications
![Page 6: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/6.jpg)
www.metcardio.org
SCOPE OF THE PROBLEMThrombotic eventsThrombotic events
Myocardial Myocardial ischemiaischemia
BleedingBleeding
Peri-procedural Peri-procedural complicationscomplications
![Page 7: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/7.jpg)
www.metcardio.org
SCOPE OF THE PROBLEM
![Page 8: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/8.jpg)
www.metcardio.org
SCOPE OF THE PROBLEM: AMI
Capewell et al, Heart 2006Capewell et al, Heart 2006
![Page 9: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/9.jpg)
www.metcardio.org
SCOPE OF THE PROBLEM: UNSTABLE ANGINA
Capewell et al, Heart 2006Capewell et al, Heart 2006
![Page 10: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/10.jpg)
www.metcardio.org
PATHWAYS TO THROMBOSIS
****
** **Myers, BUMC Proceedings 2005Myers, BUMC Proceedings 2005
![Page 11: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/11.jpg)
www.metcardio.org
MULTIPLE VULNERABLE CORONARY PLAQUES IN PATIENTS WITH AMI
Asakura et al, J Am Coll Cardiol 2001Asakura et al, J Am Coll Cardiol 2001
![Page 12: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/12.jpg)
www.metcardio.org
MULTIPLE RUPTURED CORONARY PLAQUES IN PATIENTS WITH ACS
![Page 13: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/13.jpg)
www.metcardio.org
ENDOTHELIALIZATION OF STENT STRUTS
Guagliumi et al, Ital Heart J 2003
SES BMS
Guagliumi et al, Ital Heart J 2003
![Page 14: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/14.jpg)
www.metcardio.org
ON TOP OF THIS:VARIABILITY IN RESPONSE TO ANTITHROMBOTIC THERAPY
![Page 15: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/15.jpg)
www.metcardio.org
VARIABILITY IN RESPONSEChange in ADP-Induced
Platelet Aggregation75 mg chronic dosing
Serebruany et al, J Am Coll Cardiol 2005 Hochholzer et al, Circulation 2005
Time from loading dose to cath (h)
Maximal aggregation 5 µmol/L ADP (%)following 600 mg loading dose
0 2 4 6 8 100
20
40
60
80
100
N=1001
Num
ber
of P
atie
nts N=544
Relative change in aggregation
![Page 16: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/16.jpg)
www.metcardio.org
GENETIC VARIABILITY IN RISK OF STENT THROMBOSIS
Mega et al, New Engl J Med 2009
![Page 17: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/17.jpg)
www.metcardio.org
FAILING STENTS: THROMBOSIS VS RESTENOSIS
Schuchman, New Engl J Med 2006
![Page 18: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/18.jpg)
www.metcardio.org
MECHANISMS OF THROMBOSIS: VIRCHOW'S TRIAD
BLOOD FLOW
VESSEL
![Page 19: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/19.jpg)
www.metcardio.org
MECHANISMS OF STENT THROMBOSIS
PATIENT FACTORS
LESION FACTORS
PROCEDURAL & MEDICAL
RX FACTORS
![Page 20: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/20.jpg)
www.metcardio.org
PREDICTING THROMBOSIS ACCORDING TO DIABETES
Machecourt et al, J Am Coll Cardiol 2009
![Page 21: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/21.jpg)
www.metcardio.org
PREDICTING THROMBOSIS ACCORDING TO STENT LENGTH
Moreno et al, J Am Coll Cardiol 2005
![Page 22: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/22.jpg)
www.metcardio.org
PREDICTORS OF STENT THROMBOSIS AFTER ACS
Van Werkum et al, J Am Coll Cardiol 2009
OR
![Page 23: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/23.jpg)
www.metcardio.org
LEARNING GOALS
• SCOPE OF THE PROBLEM
• MENU A LA CARTE OR TABLE D’HOTE?
• MY OWN RECIPE
![Page 24: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/24.jpg)
www.metcardio.org
ASPIRIN
![Page 25: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/25.jpg)
www.metcardio.org
0.00
0.05
0.10
0.15
0.20
0.25
0 3 6 9 12
Months
Pro
bab
ility
of
de
ath
or
MI Placebo
ASA 75 mg
Risk ratio after 1 year 0.5295% Cl 0.37–0.72 (P=0.0001)
Wallentin et al, JACC 1991
ASPIRIN IN UNSTABLE ANGINA
![Page 26: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/26.jpg)
www.metcardio.org
CLOPIDOGREL
![Page 27: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/27.jpg)
www.metcardio.org
Cu
mu
lati
ve h
azar
d r
ates
fo
r C
V d
eath
/MI
Days of follow-up
a = median time PCI (10 days)b = 30 days after median time of PCI
0.15
0.10
0.05
0.0
1000
40 100 200 300 400
a b
PlaceboClopidogrel
12.6%
8.8%
1.9% ARR31% RRRP=0.002N=2,658
PCI-CURE
Mehta et al, Lancet 2001
![Page 28: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/28.jpg)
www.metcardio.org
IMPACT OF ANTIPLATELET THERAPY INTENSITY
Mehta et al, Lancet 2010
Clopidogrel 600+150 mg
Clopidogrel 300+75 mg
P
Definite stent thrombosis
0.7% 1.2% 0.002
Myocardial infarction 2.0% 2.6% 0.012
Stroke 0.4% 0.4% 0.59
Cardiovascular death 1.9% 1.9% 0.68
Myocardial infarction or stent thrombosis
3.0% 3.7% 0.008
Cardiovascular death, myocardial infarction, or
stroke3.9% 4.5% 0.036
30-day results of the CURRENT-OASIS 7 Trial
![Page 29: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/29.jpg)
www.metcardio.org
SUMMARY OF EVIDENCE ON CLOPIDOGREL LOADING
Lotrionte et al, Am J Cardio 2007;100:1199-1206
![Page 30: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/30.jpg)
www.metcardio.org
ABCIXIMAB
![Page 31: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/31.jpg)
www.metcardio.orgKastrati et al, JAMA 2006
BENEFITS OF ABCIXIMAB IN ACS PATIENTS PRETREATED WITH 600 MG
CLOPIDOGREL
*Death/MI/urgent TVR
*
600 mg clopidogrel500 mg ASA
>2 h before PCI
![Page 32: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/32.jpg)
www.metcardio.org
PRASUGREL
![Page 33: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/33.jpg)
www.metcardio.org
THE TRITON-TIMI 38
0
0.5
1
1.5
2
0 50 100 150 200 250 300 350 400 450
% o
f sub
ject
s ha
ving
D
ES
thro
mbo
sis
Hazard ratio 0.36 [0.22-0.58]P<0.0001
2.31%
0.84%
Days
CLOPIDOGREL
PRASUGREL
![Page 34: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/34.jpg)
www.metcardio.org
THE TRITON-TIMI 38
Wiviott et al, Lancet 2008;371:1353-63
![Page 35: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/35.jpg)
www.metcardio.org
TICAGRELOR
![Page 36: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/36.jpg)
www.metcardio.org
THE PLATO TRIAL
Wallentin et al, NEJM 2009
![Page 37: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/37.jpg)
www.metcardio.org
THE PLATO TRIAL
Wallentin et al, NEJM 2009
![Page 38: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/38.jpg)
www.metcardio.org
THE PLATO TRIAL
Wallentin et al, NEJM 2009
![Page 39: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/39.jpg)
www.metcardio.org
WHEN IS MUCH TOO MUCH?
![Page 40: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/40.jpg)
www.metcardio.org
LEARNING GOALS
• SCOPE OF THE PROBLEM
• MENU A LA CARTE OR TABLE D’HOTE?
• MY OWN RECIPE
![Page 41: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/41.jpg)
www.metcardio.org
INDIRECT COMPARISON OF PRASUGREL VS. TICAGRELOR
Funnel plots comparing prasugrel vs. ticagrelor for the risk of key clinical events. Odds ratios (OR) <1.0 favor prasugrel, whereas odds ratios>1.0 favor ticagrelor.
![Page 42: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/42.jpg)
www.metcardio.org
CABG Medical Rx
Out-of-hospital EMSER
Clopidogrel,Prasugrel orTicagrelor
Ticagrelor Clopidogrel orTicagrelor
Clopidogrel orTicagrelor
Intra-hospital transfer
Wait-and-see
thrombotic risk bleeding risk
thrombotic risk bleeding risk
thrombotic risk bleeding risk
thrombotic risk bleeding risk
Wait-and-see Prasugrel orTicagrelor
pPCI with BMS pPCI with DES
Clopidogrel,Prasugrel orTicagrelor
Coronary angiography
Appraisal of thrombotic and bleeding risks – aspirin unless bleeding risk prohibitive
![Page 43: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/43.jpg)
www.metcardio.org
TAKE HOME MESSAGE
THROMBOSIS
BLEEDING
![Page 44: If I had an acute coronary syndrome, which antiplatelet agent would I prefer?](https://reader035.fdocuments.in/reader035/viewer/2022070409/568144d6550346895db1a139/html5/thumbnails/44.jpg)
www.metcardio.org
Thank you for your attention
For any correspondence: [email protected]
For these and further slides on these topics feel free to visit the metcardio.org website:
http://www.metcardio.org/slides.html